221 related articles for article (PubMed ID: 26100498)
1. Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands.
van Meer S; de Man RA; Coenraad MJ; Sprengers D; van Nieuwkerk KM; Klümpen HJ; Jansen PL; IJzermans JN; van Oijen MG; Siersema PD; van Erpecum KJ
J Hepatol; 2015 Nov; 63(5):1156-63. PubMed ID: 26100498
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
3. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
4. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
5. Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.
Liu W; Zheng Y; Zou R; Shen J; He W; Yang Z; Zhang Y; Li B; Yuan Y
BMC Cancer; 2018 Nov; 18(1):1186. PubMed ID: 30497418
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
Eskens FA; van Erpecum KJ; de Jong KP; van Delden OM; Klumpen HJ; Verhoef C; Jansen PL; van den Bosch MA; Méndez Romero A; Verheij J; Bloemena E; de Man RA
Neth J Med; 2014 Jul; 72(6):299-304. PubMed ID: 25319854
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
Wang JH; Chang KC; Kee KM; Chen PF; Yen YH; Tseng PL; Kuo YH; Tsai MC; Hung CH; Chen CH; Tai WC; Tsai LS; Chen SC; Lin SC; Lu SN
Am J Gastroenterol; 2013 Mar; 108(3):416-24. PubMed ID: 23318478
[TBL] [Abstract][Full Text] [Related]
9. Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program.
Chen WT; Fernandes ML; Lin CC; Lin SM
J Surg Oncol; 2011 Feb; 103(2):133-9. PubMed ID: 21259246
[TBL] [Abstract][Full Text] [Related]
10. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
[TBL] [Abstract][Full Text] [Related]
11. Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.
Han KH; Kim DY; Park JY; Ahn SH; Kim J; Kim SU; Kim JK; Lee KS; Chon CY
J Clin Gastroenterol; 2013 Jul; 47(6):538-44. PubMed ID: 23340065
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study.
Kennedy NA; Rodgers A; Altus R; McCormick R; Wundke R; Wigg AJ
Intern Med J; 2013 Jul; 43(7):772-7. PubMed ID: 23611607
[TBL] [Abstract][Full Text] [Related]
13. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U;
Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210
[TBL] [Abstract][Full Text] [Related]
14. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
15. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
16. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.
Toyoda H; Kumada T; Tada T; Mizuno K; Hiraoka A; Tsuji K; Ishikawa T; Akita T; Tanaka J
Liver Int; 2018 Dec; 38(12):2260-2268. PubMed ID: 29981527
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.
Miura JT; Johnston FM; Tsai S; Eastwood D; Banerjee A; Christians KK; Turaga KK; Gamblin TC
HPB (Oxford); 2015 Oct; 17(10):896-901. PubMed ID: 26228076
[TBL] [Abstract][Full Text] [Related]
18. Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
Kim HY; Nam JY; Lee JH; Lee HA; Chang Y; Lee HY; Cho H; Lee DH; Cho YY; Cho EJ; Yu SJ; Lee JM; Kim YJ; Yoon JH
Aliment Pharmacol Ther; 2018 Jun; 47(11):1490-1501. PubMed ID: 29611209
[TBL] [Abstract][Full Text] [Related]
19. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
Khalaf N; Ying J; Mittal S; Temple S; Kanwal F; Davila J; El-Serag HB
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):273-281.e1. PubMed ID: 27521507
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
